A medication like semaglutide is a powerful tool, but it works best when it is part of a larger, sustainable lifestyle change
If you treat those underlying conditions, you make it a beneficial positive effect of cognitive function. The existing Alzheimers drugs, Leqembi and Kisunla, target only one component of the disease: amyloid plaque in the brain
Future studies should aim to elucidate the mechanisms underlying these contradictory observations and identify the specific conditions under which GLP-1RAs might exert detrimental effects on the CNS
According to a recent press release, tirzepatide was non-inferior to dulaglutide, an agent with proven cardiovascular prevention benefits, in preventing MACE-3, defined as cardiovascular death, nonfatal heart attack, or nonfatal stroke